Klinische Neurophysiologie 2008; 39(4): 256-261
DOI: 10.1055/s-0028-1104568
Originalia

© Georg Thieme Verlag KG Stuttgart · New York

Genetik von Schlafstörungen

Genetics of Sleep DisordersP. Young 1
  • 1Klinik und Poliklinik für Neurologie, Sektion für Schlafmedizin, Münster
Further Information

Publication History

Publication Date:
12 January 2009 (online)

Zusammenfassung

Viele Schlafstörungen mit genetischen Grundlagen sind nicht einzelnen Genen zuzuordnen. Für die meisten Schlafstörungen wird eine komplexe Genetik angenommen. Assoziationen zu bestimmten HLA Loci wurden für die Narkolepsie, das Schlafwandeln, die REM-Verhaltensstörung und das Kleine-Levin-Syndrom gezeigt. Mittels genomweiter Assoziations-Analyse wurden für das Restless Legs Syndrom eine Assoziation zu verschiedenen Genen gezeigt. Einzelne krankheitsverursachende Gene konnten erst für sehr wenige Schlafstörungen beschrieben werden. Hierzu zählen das Syndrom der vorverlagerten Schlafphasen und das Congenitale-Centrale-Hypoventilations Syndrom. In Zukunft sind aufgrund der technischen Möglichkeiten mittels genomweiter Assoziations-Analysen zunehmende Erkenntnisse zu Assoziationen mit neuen Genloci zu erwarten. Diese werden es ermöglichen, die biologischen Grundlagen von Schlafstörungen besser zu verstehen und neue Therapieoptionen zu entwickeln. Für die genetische Erforschung von Schlafstörungen ist die exakte Phänotypisierung, die auch eine kardiorespiratorischen Polysomnografie beinhaltet, unerlässlich.

Abstract

Many sleep disorders have a strong genetic background and are rarely monogenetic. Most sleep disorders are assumed to be complex genetic disorders. Associations between the HLA system and narcolepsy, sleep walking, REM behavourial disorder and Kleine-Levin syndrome have been shown. Restless legs syndrome was found to be associated with different genes using a genome-wide association approach. In future, new associations will be found as a consequence of new technologies that improve our knowledge about the biological basis of sleep disorders. This knowledge will lead to new therapeutic options. For further investigations, the exact description of the specific phenotypes will be essential using cardiorespiratory polysomnography as one of the most important prerequisites.

Literatur

  • 1 Linkowski P. EEG sleep patterns in twins.  J Sleep Res. 1999;  8 ((Suppl 1)) 11-13
  • 2 Armitage R, Landis C, Hoffmann R. et al . The impact of a 4-h sleep delay on slow wave activity in twins discordant for chronic fatigue syndrome.  Sleep. 2007;  30 657-662
  • 3 Koskenvuo M, Hublin C, Partinen M. et al . Heritability of diurnal type: a nationwide study of 8 753 adult twin pairs.  J Sleep Res. 2007;  16 156-162
  • 4 Watson NF, Goldberg J, Arguelles L. et al . Genetic and environmental influences on insomnia, daytime sleepiness, and obesity in twins.  Sleep. 2006;  29 645-649
  • 5 Dauvilliers Y, Maret S, Tafti M. Genetics of normal and pathological sleep in humans.  Sleep Med Rev. 2005;  9 91-100
  • 6 Nishino S. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.  Expert Opin Investig Drugs. 2007;  16 1785-1797
  • 7 Roecker AJ, Coleman PJ. Orexin receptor antagonists: medicinal chemistry and therapeutic potential.  Curr Top Med Chem. 2008;  8 977-987
  • 8 Lesage S, Hening WA. The restless legs syndrome and periodic limb movement disorder: a review of management.  Semin Neurol. 2004;  24 249-259
  • 9 Patel S. Restless legs syndrome and periodic limb movements of sleep: fact, fad, and fiction.  Curr Opin Pulm Med. 2002;  8 498-501
  • 10 Karatas M. Restless legs syndrome and periodic limb movements during sleep: diagnosis and treatment.  Neurologist. 2007;  13 294-301
  • 11 Satija P, Ondo WG. Restless legs syndrome: pathophysiology, diagnosis and treatment.  CNS Drugs. 2008;  22 497-518
  • 12 Stiasny K, Oertel WH, Trenkwalder C. Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder.  Sleep Med Rev. 2002;  6 253-265
  • 13 Allen RP, Picchietti D, Hening WA, Trenkwalder C. et al . Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.  Sleep Med. 2003;  4 101-119
  • 14 Desautels A, Turecki G, Montplaisir J. et al . Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q.  Am J Hum Genet. 2001;  69 1266-1270
  • 15 Montplaisir J, Godbout R, Boghen D. et al . Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study.  Neurology. 1985;  35 130-134
  • 16 Winkelmann J, Muller-Myhsok B, Wittchen HU. et al . Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families.  Ann Neurol. 2002;  52 297-302
  • 17 Winkelmann J, Lichtner P, Putz B. et al . Evidence for further genetic locus heterogeneity and confirmation of RLS-1 in restless legs syndrome.  Mov Disord. 2006;  21 28-33
  • 18 Winkelmann J, Lichtner P, Schormair B. et al . Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome.  Mov Disord. 2008;  23 350-358
  • 19 Winkelmann J, Schormair B, Lichtner P. et al . Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.  Nat Genet. 2007;  39 1000-1006
  • 20 Bonati MT, Ferini-Strambi L, Aridon P. et al . Autosomal dominant restless legs syndrome maps on chromosome 14q.  Brain. 2003;  126 1485-1492
  • 21 Winkelman JW. Periodic limb movements in sleep–endophenotype for restless legs syndrome?.  N Engl J Med. 2007;  357 703-705
  • 22 Trotti LM, Bhadriraju S, Rye DB. An update on the pathophysiology and genetics of restless legs syndrome.  Curr Neurol Neurosci Rep. 2008;  8 281-287
  • 23 Winkelmann J. Genetics of restless legs syndrome.  Curr Neurol Neurosci Rep. 2008;  8 211-216
  • 24 Hublin C, Kaprio J, Partinen M. et al . Prevalence and genetics of sleepwalking: a population-based twin study.  Neurology. 1997;  48 177-181
  • 25 Abe K, Shimakawa M. Predisposition to sleep-walking.  Psychiatr Neurol (Basel). 1966;  152 306-312
  • 26 Hublin C, Kaprio J, Partinen M. et al . Parasomnias: co-occurrence and genetics.  Psychiatr Genet. 2001;  11 65-70
  • 27 Gau SF, Soong WT. Psychiatric comorbidity of adolescents with sleep terrors or sleepwalking: a case-control study.  Aust N Z J Psychiatry. 1999;  33 734-739
  • 28 Kales A, Soldatos CR, Bixler EO. et al . Hereditary factors in sleepwalking and night terrors.  Br J Psychiatry. 1980;  137 111-118
  • 29 Abe K, Amatomi M, Oda N. Sleepwalking and recurrent sleeptalking in children of childhood sleepwalkers.  Am J Psychiatry. 1984;  141 800-801
  • 30 Lecendreux M, Bassetti C, Dauvilliers Y. et al . HLA and genetic susceptibility to sleepwalking.  Mol Psychiatry. 2003;  8 114-117
  • 31 Schenck CH, Boyd JL, Mahowald MW. A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases.  Sleep. 1997;  20 972-981
  • 32 Hublin C, Kaprio J, Partinen M. et al . Limits of self-report in assessing sleep terrors in a population survey.  Sleep. 1999;  22 89-93
  • 33 Hallstrom T. Night terror in adults through three generations.  Acta Psychiatr Scand. 1972;  48 350-352
  • 34 DiMario  Jr  FJ, Emery  3rd  ES. The natural history of night terrors.  Clin Pediatr (Phila). 1987;  26 505-511
  • 35 Schenck CH, Bundlie SR, Patterson AL. et al . Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults.  Jama. 1987;  257 1786-1789
  • 36 Schenck CH, Mahowald MW. Rapid eye movement sleep parasomnias.  Neurol Clin. 2005;  23 1107-1126
  • 37 Boeve BF, Silber MH, Parisi JE. et al . Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.  Neurology. 2003;  61 40-45
  • 38 Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.  Neurology. 1996;  46 388-393
  • 39 Comella CL, Nardine TM, Diederich NJ. et al . Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease.  Neurology. 1998;  51 526-529
  • 40 Trenkwalder C. Sleep dysfunction in Parkinson's disease.  Clin Neurosci. 1998;  5 107-114
  • 41 Macaluso GM, Guerra P, Giovanni G Di. et al . Sleep bruxism is a disorder related to periodic arousals during sleep.  J Dent Res. 1998;  77 565-573
  • 42 Boutros NN, Montgomery MT, Nishioka G. et al . The effects of severe bruxism on sleep architecture: a preliminary report.  Clin Electroencephalogr. 1993;  24 59-62
  • 43 Lindqvist B. Bruxism in twins.  Acta Odontol Scand. 1974;  32 177-187
  • 44 Walters AS. Clinical identification of the simple sleep-related movement disorders.  Chest. 2007;  131 1260-1266
  • 45 Kato T, Dal-Fabbro C, Lavigne GJ. Current knowledge on awake and sleep bruxism: overview.  Alpha Omegan. 2003;  96 24-32
  • 46 Kato T, Masuda Y, Morimoto T. Patterns of masseter muscle activities during sleep in guinea pigs.  Arch Oral Biol. 2007;  52 385-386
  • 47 Kato T, Montplaisir JY, Blanchet PJ. et al . Idiopathic myoclonus in the oromandibular region during sleep: a possible source of confusion in sleep bruxism diagnosis.  Mov Disord. 1999;  14 865-871
  • 48 Kato T, Thie NM, Huynh N. et al . Topical review: sleep bruxism and the role of peripheral sensory influences.  J Orofac Pain. 2003;  17 191-213
  • 49 Doering S, Boeckmann JA, Hugger S. et al . Ambulatory polysomnography for the assessment of sleep bruxism.  J Oral Rehabil. 2008;  35 572-576
  • 50 Aldrich MS. Narcolepsy.  Neurology. 1992;  42 34-43
  • 51 Selbach O, Haas HL. Hypocretins: the timing of sleep and waking.  Chronobiol Int. 2006;  23 63-70
  • 52 Zeitzer JM, Nishino S, Mignot E. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.  Trends Pharmacol Sci. 2006;  27 368-374
  • 53 Nishino S, Ripley B, Overeem S. et al . Hypocretin (orexin) deficiency in human narcolepsy.  Lancet. 2000;  355 39-40
  • 54 Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy.  Clin Neurophysiol. 2003;  114 2000-2017
  • 55 Peraita-Adrados R, Ezpeleta D, Balas A. et al . Narcolepsy-cataplexy syndrome associated with DRB1*0806-DQB*0602 haplotype in a Caucasian patient.  Sleep Res Online. 1999;  2 29-31
  • 56 Chabas D, Taheri S, Renier C. et al . The genetics of narcolepsy.  Annu Rev Genomics Hum Genet. 2003;  4 459-483
  • 57 Lin L, Hungs M, Mignot E. Narcolepsy and the HLA region.  J Neuroimmunol. 2001;  117 9-20
  • 58 Mignot E, Tafti M, Dement WC. et al . Narcolepsy and immunity.  Adv Neuroimmunol. 1995;  5 23-37
  • 59 Planelles D, Puig N, Beneto A. et al . HLA-DQA, -DQB and -DRB allele contribution to narcolepsy susceptibility.  Eur J Immunogenet. 1997;  24 409-421
  • 60 Kawashima M, Tamiya G, Oka A. et al . Genomewide association analysis of human narcolepsy and a new resistance gene.  Am J Hum Genet. 2006;  79 252-263
  • 61 Lin L, Faraco J, Li R. et al . The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.  Cell. 1999;  98 365-376
  • 62 Miyagawa T, Kawashima M, Nishida N. et al . Variant between CPT1B and CHKB associated with susceptibility to narcolepsy.  Nat Genet. 2008;  40 1324-1328
  • 63 Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease.  Jama. 2003;  290 1906-1914
  • 64 Weiss JW, Launois SH, Anand A. et al . Cardiovascular morbidity in obstructive sleep apnea.  Prog Cardiovasc Dis. 1999;  41 367-376
  • 65 Dopp JM, Reichmuth KJ, Morgan BJ. Obstructive sleep apnea and hypertension: mechanisms, evaluation, and management.  Curr Hypertens Rep. 2007;  9 529-534
  • 66 Dziewas R, Humpert M, Hopmann B. et al . Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims.  J Neurol. 2005;  252 1394-1398
  • 67 Dziewas R, Waldmann N, Bontert M. et al . Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study.  J Neurol Neurosurg Psychiatry. 2008;  79 829-831
  • 68 Young T, Evans L, Finn L. et al . Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women.  Sleep. 1997;  20 705-706
  • 69 Young T, Palta M, Dempsey J. et al . The occurrence of sleep-disordered breathing among middle-aged adults.  N Engl J Med. 1993;  328 1230-1235
  • 70 Punjabi NM. The epidemiology of adult obstructive sleep apnea.  Proc Am Thorac Soc. 2008;  5 136-143
  • 71  . Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.  Sleep. 1999;  22 667-689
  • 72 Redline S, Budhiraja R, Kapur V. et al . The scoring of respiratory events in sleep: reliability and validity.  J Clin Sleep Med. 2007;  3 169-200
  • 73 Banno K, Kryger MH. Sleep apnea: clinical investigations in humans.  Sleep Med. 2007;  8 400-426
  • 74 Muntz H, Wilson M, Park A. et al . Sleep disordered breathing and obstructive sleep apnea in the cleft population.  Laryngoscope. 2008;  118 348-353
  • 75 Schwab RJ. Genetic determinants of upper airway structures that predispose to obstructive sleep apnea.  Respir Physiol Neurobiol. 2005;  147 289-298
  • 76 Guilleminault C, Partinen M, Hollman K. et al . Familial aggregates in obstructive sleep apnea syndrome.  Chest. 1995;  107 1545-1551
  • 77 Carmelli D, Colrain IM, Swan GE. et al . Genetic and environmental influences in sleep-disordered breathing in older male twins.  Sleep. 2004;  27 917-922
  • 78 Dematteis M, Pepin JL, Jeanmart M. et al . Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study.  Lancet. 2001;  357 267-272
  • 79 Palmer LJ, Buxbaum SG, Larkin EK. et al . Whole genome scan for obstructive sleep apnea and obesity in African-American families.  Am J Respir Crit Care Med. 2004;  169 1314-1321
  • 80 Foley DJ, Masaki K, White L. et al . Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages.  Jama. 2001;  286 1447-1448
  • 81 Kadotani H, Kadotani T, Young T. et al . Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults.  Jama. 2001;  285 2888-2890
  • 82 Gozal D, Capdevila OS, Kheirandish-Gozal L. et al . APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children.  Neurology. 2007;  69 243-249
  • 83 Kalra M, Chakraborty R. Genetic susceptibility to obstructive sleep apnea in the obese child.  Sleep Med. 2007;  8 169-175
  • 84 Kalra M, Pal P, Kaushal R. et al . Association of ApoE genetic variants with obstructive sleep apnea in children.  Sleep Med. 2008;  9 260-265
  • 85 Larkin EK, Patel SR, Redline S. et al . Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak.  Genet Epidemiol. 2006;  30 101-110
  • 86 Trochet D, Hong SJ, Lim JK. et al . Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction.  Hum Mol Genet. 2005;  14 3697-3708
  • 87 Gaultier C, Amiel J, Dauger S. et al . Genetics and early disturbances of breathing control.  Pediatr Res. 2004;  55 729-733
  • 88 Dubreuil V, Ramanantsoa N, Trochet D. et al . A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neurons.  Proc Natl Acad Sci USA. 2008;  105 1067-1072
  • 89 Gery S, Koeffler HP. The role of circadian regulation in cancer.  Cold Spring Harb Symp Quant Biol. 2007;  72 459-464
  • 90 McClung CA. Role for the Clock gene in bipolar disorder.  Cold Spring Harb Symp Quant Biol. 2007;  72 637-644
  • 91 Sehgal A, Joiner W, Crocker A. et al . Molecular analysis of sleep: wake cycles in Drosophila.  Cold Spring Harb Symp Quant Biol. 2007;  72 557-564
  • 92 Siepka SM, Yoo SH, Park J. et al . Genetics and neurobiology of circadian clocks in mammals.  Cold Spring Harb Symp Quant Biol. 2007;  72 251-259
  • 93 Brown SA, Kunz D, Dumas A. et al . Molecular insights into human daily behavior.  Proc Natl Acad Sci USA. 2008;  105 1602-1607
  • 94 Morgenthaler T, Alessi C, Friedman L. et al . Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.  Sleep. 2007;  30 519-529
  • 95 Okawa M, Uchiyama M. Circadian rhythm sleep disorders: characteristics and entrainment pathology in delayed sleep phase and non-24-h sleep-wake syndrome.  Sleep Med Rev. 2007;  11 485-496
  • 96 Castro RM, Barbosa AA, Pedrazzoli M. et al . Casein kinase I epsilon (CKIvarepsilon) N408 allele is very rare in the Brazilian population and is not involved in susceptibility to circadian rhythm sleep disorders.  Behav Brain Res. 2008;  193 156-157
  • 97 Ebisawa T, Uchiyama M, Kajimura N. et al . Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome.  EMBO Rep. 2001;  2 342-346
  • 98 Toh KL, Jones CR, He Y. et al . An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.  Science. 2001;  291 1040-1043
  • 99 Arnulf I, Zeitzer JM, File J. et al . Kleine-Levin syndrome: a systematic review of 186 cases in the literature.  Brain. 2005;  128 2763-2776
  • 100 Pearce JM. Kleine-Levin syndrome: history and brief review.  Eur Neurol. 2008;  60 212-214
  • 101 Katz JD, Ropper AH. Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells.  Arch Neurol. 2002;  59 1959-1961
  • 102 BaHammam AS, GadElRab MO, Owais SM. et al . Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome.  Sleep Med. 2008;  9 575-578
  • 103 Dauvilliers Y, Baumann CR, Carlander B. et al . CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.  J Neurol Neurosurg Psychiatry. 2003;  74 1667-1673
  • 104 Moon HJ, Choi JS, Park EJ. et al . Effects of chromosomal variations on pharmacokinetic activity of zolpidem in healthy volunteers: an array-based comparative genomic hybridization study.  Biochem Biophys Res Commun. 2007;  356 981-987
  • 105 Bunney WE, Bunney BG. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression.  Neuropsychopharmacology. 2000;  22 335-345
  • 106 Lin SH, Civelli O. Orphan G protein-coupled receptors: targets for new therapeutic interventions.  Ann Med. 2004;  36 204-214

Korrespondenzadresse

Univ.-Prof. Dr. P. Young

Klinik und Poliklinik für Neurologie

Sektion Schlafmedizin

Albert-Schweitzer-Str. 33

48129 Münster

Email: young@uni-muenster.de

    >